Christopher Graber, M.D., M.P.H.

A Short Biography:

Christopher Graber, MD MPH, FIDSA, is a Professor of Clinical Medicine at the David Geffen School of Medicine at UCLA and a faculty member of the Infectious Diseases Section at the VA Greater Los Angeles Healthcare System.  He is Program Director of the UCLA Multicampus Fellowship in Infectious Diseases and medical director of the antimicrobial stewardship program at the VA Greater Los Angeles Healthcare System.  His research interests are cognitive support for antimicrobial decision-making and implementation of antimicrobial stewardship initiatives.   

Work Titles
UCLA Professor of Clinical Medicine, Infectious Diseases
M.D., University of Texas-Southwestern, 2001
M.P.H., University of California, Berkeley, 2007
B.A., University of Virginia, 1996
2007 University of California, San Francisco, University of California, San Francisco
2005 Seattle VA Medical Center, Seattle VA Medical Center
2004 University of Washington, University of Washington
2007 ABIM, American Board of Internal Medicine
2004 ABIM, American Board of Internal Medicine
Certification Type:
2004 California, California

Contact Information:

Work Email Address:


Work Phone Number:

310 478-3711 x40804

Office Address:

VA Greater Los Angeles Healthcare System
11301 Wilshire Blvd, 111-F
Los Angeles, CA 90073

Research Interest:

Antimicrobial Stewardship

My research is a direct extension of my clinical work, which involves directing the VA GLA antimicrobial stewardship program and infectious diseases telemedicine program, co-directing our outpatient parenteral antimicrobial therapy program, and participating in developing national stewardship initiatives as a part of the Metrics and Innovations Workgroup and Research-Operations Collaborative Workgroup of the VA Antimicrobial Stewardship Task Force. 

Antimicrobial Stewardship

Current projects include expansion of an “antibiotic time out” for broad-spectrum antimicrobial use, analysis of antimicrobial stewardship activites, and development of cognitive support tools for stewardship at individual VA facilities nationwide as well as local implementation of a project to reduce treatment of asymptomatic bacteriuria. Prior projects that I have completed at GLA (typically with trainees) include analyses of potential nephrotoxicity associated with elevated vancomycin trough levels, the impact of ertapenem’s addition to our formulary on antmicrobial usage and resistance patterns in nosocomial Enterobacteriaceae and Pseudomonas isolates, the effectiveness and cost savings of our outpatient parenteral antimicrobial therapy program, and reviews of the clinical and microbiologic relevance of antibiotic pharmacokinetics/pharmacodynamics and antibiotic options for infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae.

Detailed Biography:

Dr. Graber attended the University of Virginia as an undergraduate, where he was captain of the varsity swimming and diving team and competed in the 1992 and 1996 United States Olympic Trials. He went on to graduate from the University of Texas-Southwestern Medical School in 2001 and completed a residency in internal medicine at the University of Washington in 2004. He was chief resident at the Seattle VA Medical Center from 2004-2005. Prior to joining the faculty at UCLA and the VA Greater Los Angeles in January 2008, Dr. Graber completed his infectious diseases fellowship at the University of California, San Francisco and a Masters of Public Health degree in epidemiology from the University of California, Berkeley.

View a up-to-date publication list: My publications

Does this profile need updating? Contact Us